MedTrace Logo

D-chiro-inositol Increases Androgens and Reduces Estrogens in Human Serum

NCT04615767 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-08-02

No results posted yet for this study

Summary

The aim of this pilot study is to test the effect of a 30 day-D-chiro-inositol oral treatment on a set of clinical parameters (mainly sex hormones) in a group of male volunteers selected by their age and BMI to investigate if D-chiro-inositol acts as an aromatase inhibitor.

Conditions

  • Low Serum Testosterone Levels in Man

Interventions

DIETARY_SUPPLEMENT

D-chiro-inositol

as described previously

Sponsors & Collaborators

  • AGUNCO Obstetrics and Gynecology Centre

    lead OTHER

Principal Investigators

  • Giovanni Monastra · Systems Biology Group Lab, Rome, Italy

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-28
Primary Completion
2020-12-06
Completion
2020-12-16

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04615767 on ClinicalTrials.gov